FDA News & Notes - Week of September 26, 2011

Sep 26, 2011, 14:15 ET from U.S. Food and Drug Administration

SILVER SPRING, Md., Sept. 26, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of September 26, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Events and Speeches for the Commissioner and FDA leadership:
Wednesday, 9/28 – AdvaMed 2011 Conference. HHS Secretary Kathleen Sebelius, John M. Taylor, J.D., counselor to the FDA Commissioner, and Jeffrey Shuren, M.D., director of FDA's Center for Devices and Radiological Health, discuss medical device reforms and the FDA at the AdvaMed 2011 conference. 7:30 a.m. Walter E. Washington Convention Center, 801 Mount Vernon Place, N.W., Hall D, Washington, D.C.
Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

Meetings, Workshops and Congressional Testimony:
Monday, 9/26 – Public Workshop: Center for Drug Evaluation and Research: Approach to Addressing Drug Shortages. The FDA workshop is intended to provide information for, and to gain insight from, professional societies, patient advocates, industry, consumer groups, health care professionals, and others. 8:30 a.m., 10903 New Hampshire Ave., Building 31, Room 1503, Silver Spring, Md.
Press Office Contact: Shelly Burgess, 301-796-4651, shelly.burgess@fda.hhs.gov

Monday, 9/26 – Start of a two-day Tissue Adhesives/Soft Tissue Workshop on innovation and the appropriate regulatory pathways to develop new tissue adhesive biomaterials. 8 a.m., 10903 New Hampshire Ave., Building 2, Room A-2031, Silver Spring, Md.
Press Office Contact: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov

Thursday, 10/13 – Circulatory System Devices Panel of the Medical Devices Advisory Committee  will discuss, make recommendations, and vote on information related to the premarket approval application for the ZILVER-PTX Drug-Eluting Stent submitted by Cook Inc. 8 a.m., Hilton Washington D.C. North/Gaithersburg, 620 Perry Pkwy., Gaithersburg, Md.
Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

On the Web:
Letter to LASIK eye care health professionals reminding them of their responsibilities in advertising.
Press Office Contact: Erica V. Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov

FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov
List of FDA press officers and beats

More Resources:
FDA News and Events

FDA Photos (Flickr)

Consumer Health Information

SOURCE U.S. Food and Drug Administration



RELATED LINKS

http://www.fda.gov/